La malformation de Chiari type 1 (MCI) est une anomalie congénitale de la jonction cranio-cérébrale fréquente avec une incidence de 1:1280. MCI est caractérisée par la descente des amygdales cérébelleuses à travers le foramen magnum et est souvent associée à la syringomyélie. Les causes de cette maladie semblent être multifactorielles incluant des facteurs génétiques. La MCI est similaire à une malformation fréquente chez la race des Griffon Bruxellois (GB) connue sous le nom de Malformation Chiari-like (MCL). Le modèle canin offre l’avantage d’une forte homogénéité génétique réduisant ainsi la complexité de la maladie et facilitant l’identification d’un locus causatif. Une étude d’association du génome entier sur une cohorte de 56 GB suivie d’une cartographie fine sur une cohorte de 217 GB a identifié un locus fortement associé à la MCL sur le chromosome 2 (22 SNPs, valeur P= 7 x 10-8) avec un haplotype de 1.9 Mb plus fréquent chez les non affectés. Une seconde étude d’association du génome entier sur une cohorte de 113 GB a permis d’identifier un 2 ème locus fortement associé à la MCL sur le chromosome 13 (25 SNPs , valeur P= 3 x 10 -7) avec un haplotype de 4 Mb surreprésenté chez les non affectés. Ces régions candidates constituent la première étape vers l’identification de gènes causatifs pour la MCL. Notre étude offre un point d’entrée vers une meilleure compréhension des mécanismes moléculaires sous-tendant la pathogénèse de la MCI humaine. / Chiari I malformation (CMI) represents a common congenital abnormality of the craniocerebral junction with an estimated incidence of 1 in 1280. CMI is characterized by a descent of the cerebellar tonsils into the foramen magnum, often in association with syringomyelia. The developmental defect in CMI is thought to be the result of an underdeveloped occipital bone and small posterior fossa. The etiology of CMI is thought to be multifactorial involving genetic factors. CMI in humans is similar to a condition in the dog called Chiari-like malformation (CM) that is particularly common in the Griffon Bruxellois (GB) breeds. A genome wide association study on a 56 GB cohort followed by a fine mapping in a 217 GB cohort have identified a locus on chromosome 2 that was strongly associated with CM (22 SNPs, P value= 7 x 10-8). Haploview analysis of this locus identified a haplotype of 1.9 Mb that was more frequent in non-affected dogs. A second genome wide association study in a 113 GB cohort lead to the identification of another locus on chromosome 13 that was strongly associated with CM (25 SNPs , P value= 3 x 10-7). Analysis of this region identified a 4Mb haplotype that was more frequent in non-affected dogs. Our study constitutes the first essential step towards identification of the causative genes in CM. Our study provides an entry point for better understanding of the molecular genetic mechanisms underlying the pathogenesis of human CMI.

La malformation de Chiari type 1 (MCI) est une anomalie congénitale de la jonction cranio-cérébrale fréquente avec une incidence de 1:1280. MCI est caractérisée par la descente des amygdales cérébelleuses à travers le foramen magnum et est souvent associée à la syringomyélie. Les causes de cette maladie semblent être multifactorielles incluant des facteurs génétiques. La MCI est similaire à une malformation fréquente chez la race des Griffon Bruxellois (GB) connue sous le nom de Malformation Chiari-like (MCL). Le modèle canin offre l’avantage d’une forte homogénéité génétique réduisant ainsi la complexité de la maladie et facilitant l’identification d’un locus causatif. Une étude d’association du génome entier sur une cohorte de 56 GB suivie d’une cartographie fine sur une cohorte de 217 GB a identifié un locus fortement associé à la MCL sur le chromosome 2 (22 SNPs, valeur P= 7 x 10-8) avec un haplotype de 1.9 Mb plus fréquent chez les non affectés. Une seconde étude d’association du génome entier sur une cohorte de 113 GB a permis d’identifier un 2 ème locus fortement associé à la MCL sur le chromosome 13 (25 SNPs , valeur P= 3 x 10 -7) avec un haplotype de 4 Mb surreprésenté chez les non affectés. Ces régions candidates constituent la première étape vers l’identification de gènes causatifs pour la MCL. Notre étude offre un point d’entrée vers une meilleure compréhension des mécanismes moléculaires sous-tendant la pathogénèse de la MCI humaine. / Chiari I malformation (CMI) represents a common congenital abnormality of the craniocerebral junction with an estimated incidence of 1 in 1280. CMI is characterized by a descent of the cerebellar tonsils into the foramen magnum, often in association with syringomyelia. The developmental defect in CMI is thought to be the result of an underdeveloped occipital bone and small posterior fossa. The etiology of CMI is thought to be multifactorial involving genetic factors. CMI in humans is similar to a condition in the dog called Chiari-like malformation (CM) that is particularly common in the Griffon Bruxellois (GB) breeds. A genome wide association study on a 56 GB cohort followed by a fine mapping in a 217 GB cohort have identified a locus on chromosome 2 that was strongly associated with CM (22 SNPs, P value= 7 x 10-8). Haploview analysis of this locus identified a haplotype of 1.9 Mb that was more frequent in non-affected dogs. A second genome wide association study in a 113 GB cohort lead to the identification of another locus on chromosome 13 that was strongly associated with CM (25 SNPs , P value= 3 x 10-7). Analysis of this region identified a 4Mb haplotype that was more frequent in non-affected dogs. Our study constitutes the first essential step towards identification of the causative genes in CM. Our study provides an entry point for better understanding of the molecular genetic mechanisms underlying the pathogenesis of human CMI.

No description available.

Objetivos: Malformação de Chiari do tipo I (MC-I) é a principal doença malformativa congênita da junção craniovertebral, manifestando-se com ampla variedade de sinais e sintomas neurológicos. A melhor técnica cirúrgica a ser empregada no tratamento dos pacientes com malformação de Chiari do tipo I é ainda controversa. A descompressão das estruturas da fossa craniana posterior com plástica de ampliação dural é considerada procedimento padrão. Embora efetiva e de baixa morbidade, a craniectomia occipital isolada, sem abertura e ampliação dural, implica maior taxa de recidiva dos sintomas. Métodos que selecionam os pacientes quanto a necessidade da duroplastia não foram estabelecidos. O presente trabalho avalia a eficácia da mensuração intraoperatória da velocidade do fluxo do líquido cefalorraquidiano através da ultrassonografia (USG) na seleção da técnica cirúrgica a ser utilizada. Métodos: Foram analisados de forma prospectiva 49 pacientes submetidos à cirurgia para MC-I. A indicação de craniectomia da fossa posterior associada ou não à plástica de ampliação da dura-máter baseou-se na velocidade do fluxo do líquido cefalorraquidiano, mensurada pela ultrassonografia intraoperatória. Dor cervical, cefaleia e qualidade de vida foram avaliadas antes e após o tratamento cirúrgico. Resultados: Dos 49 pacientes incluídos, 36 pacientes (73%) apresentavam fluxo do líquido cefalorraquidiano superior a 3 cm/s e não foram submetidos a duroplastia ampliadora. Nos 13 (27%) pacientes com fluxo inicial inferior a 3 cm/s, indicou-se craniectomia occipital com duroplastia de ampliação. Não houve diferença significativa entre os dois grupos com relação aos parâmetros estudados. Conclusão: A ultrassonografia intraoperatória com avaliação da dinâmica e velocidade do fluxo do líquido cefalorraquidiano da junção craniovertebral auxilia a indicação de duroplastia durante descompressão da fossa craniana posterior em pacientes adultos com MC-I / Objectives: Chiari malformation Type I (CM-I) is the main congenital malformation disease of the craniovertebral junction, and may be responsible for a variety of neurological symptoms. The ideal surgical technique used to treat patients with CM-I is still controversial. Invasive procedures that enters CSF space and are associated with dural repair, are considered the gold standard. Although effective and less morbidity, isolated bone decompression without dural opening, implies greater recurrence of symptoms. Objective parameters to select patients, who need or not to have a duroplasty performed, have not been established. Our study evaluates the efficacy of intra-operative CSF flow measurement through the use of ultrasonography (USG) as a determining parameter in the selection of these patients. Methods: We analyzed prospectively 49 posterior fossa surgeries for patients with CM-I. Patients underwent decompressive surgery with or without opening of the dura mater after conducting USG intra-operatively with measured flow rate, being adopted 3cm/s flow rate as a determining value. The quality of life before and after surgery and the improvement of neck pain and headache were the parameters evaluated. Results: Of the 49 patients enrolled, 36 patients (73%) had adequate CSF flow above 3 cm / s and have not undergone duroplasty. In 13 (27%) patients with initial flow < 3 cm / s an opening in dura mater was performed together with duroplasty. There was no significant difference between the two groups regarding the parameters studied. Conclusion: Intraoperative ultrasound with measurement of CSF flow, having a flow of 3 cm / s as cut-off, allows the proper selection of patients with CM-I that can have a less invasive surgery with bone decompression without duroplasty

Objetivos: Malformação de Chiari do tipo I (MC-I) é a principal doença malformativa congênita da junção craniovertebral, manifestando-se com ampla variedade de sinais e sintomas neurológicos. A melhor técnica cirúrgica a ser empregada no tratamento dos pacientes com malformação de Chiari do tipo I é ainda controversa. A descompressão das estruturas da fossa craniana posterior com plástica de ampliação dural é considerada procedimento padrão. Embora efetiva e de baixa morbidade, a craniectomia occipital isolada, sem abertura e ampliação dural, implica maior taxa de recidiva dos sintomas. Métodos que selecionam os pacientes quanto a necessidade da duroplastia não foram estabelecidos. O presente trabalho avalia a eficácia da mensuração intraoperatória da velocidade do fluxo do líquido cefalorraquidiano através da ultrassonografia (USG) na seleção da técnica cirúrgica a ser utilizada. Métodos: Foram analisados de forma prospectiva 49 pacientes submetidos à cirurgia para MC-I. A indicação de craniectomia da fossa posterior associada ou não à plástica de ampliação da dura-máter baseou-se na velocidade do fluxo do líquido cefalorraquidiano, mensurada pela ultrassonografia intraoperatória. Dor cervical, cefaleia e qualidade de vida foram avaliadas antes e após o tratamento cirúrgico. Resultados: Dos 49 pacientes incluídos, 36 pacientes (73%) apresentavam fluxo do líquido cefalorraquidiano superior a 3 cm/s e não foram submetidos a duroplastia ampliadora. Nos 13 (27%) pacientes com fluxo inicial inferior a 3 cm/s, indicou-se craniectomia occipital com duroplastia de ampliação. Não houve diferença significativa entre os dois grupos com relação aos parâmetros estudados. Conclusão: A ultrassonografia intraoperatória com avaliação da dinâmica e velocidade do fluxo do líquido cefalorraquidiano da junção craniovertebral auxilia a indicação de duroplastia durante descompressão da fossa craniana posterior em pacientes adultos com MC-I / Objectives: Chiari malformation Type I (CM-I) is the main congenital malformation disease of the craniovertebral junction, and may be responsible for a variety of neurological symptoms. The ideal surgical technique used to treat patients with CM-I is still controversial. Invasive procedures that enters CSF space and are associated with dural repair, are considered the gold standard. Although effective and less morbidity, isolated bone decompression without dural opening, implies greater recurrence of symptoms. Objective parameters to select patients, who need or not to have a duroplasty performed, have not been established. Our study evaluates the efficacy of intra-operative CSF flow measurement through the use of ultrasonography (USG) as a determining parameter in the selection of these patients. Methods: We analyzed prospectively 49 posterior fossa surgeries for patients with CM-I. Patients underwent decompressive surgery with or without opening of the dura mater after conducting USG intra-operatively with measured flow rate, being adopted 3cm/s flow rate as a determining value. The quality of life before and after surgery and the improvement of neck pain and headache were the parameters evaluated. Results: Of the 49 patients enrolled, 36 patients (73%) had adequate CSF flow above 3 cm / s and have not undergone duroplasty. In 13 (27%) patients with initial flow < 3 cm / s an opening in dura mater was performed together with duroplasty. There was no significant difference between the two groups regarding the parameters studied. Conclusion: Intraoperative ultrasound with measurement of CSF flow, having a flow of 3 cm / s as cut-off, allows the proper selection of patients with CM-I that can have a less invasive surgery with bone decompression without duroplasty